drugset / Trial / NCT06666634
Validation of ICG-99mTc-nanoscan as Hybrid Tracer for Sentinel Node Biopsy
NaSingle-groupOpen-labelDiagnostic
Summary
99mTc-nanocolloid, the world wide used hybrid tracer for dynamic sentinel node biopsy, has recently been replaced with 99mTc-nanoscan. The hybrid form (ICG-99mTc-nanoscan) has not yet been validated, to show the similarity between the lymphatic drainage pattern between ICG-99mTc-nanoscan and 99mTc-nanoscan.
Timeline
- Start
- 2023-04-01
- Primary completion
- 2025-08
- Completion
- 2025-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 99mTc-nanoscan | Unknown | — | Other |
| Subject | ICG-99mTc-nanoscan | Unknown | — | Other |